Acute Lymphoblastic Leukemia Version 2.2025
Anal Carcinoma Version 4.2025
Central Nervous System Cancers Version 1.2025
Colon Cancer Version 4.2025
Head and Neck Cancers Version 4.2025
Histiocytic Neoplasms Version 1.2025
Multiple Myeloma Version 1.2026
Non-Small Cell Lung Cancer Version 5.2025
Pediatric Hodgkin Lymphoma Version 2.2025
Primary Cutaneous Lymphomas Version 3.2025
Systemic Light Chain Amyloidosis Version 1.2026
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Version 1.2026
Wilms Tumor (Nephroblastoma) Version 2.2025
NCCN Guidelines with Evidence Blocks - Acute Lymphoblastic Leukemia Version 2.2025
NCCN Guidelines with Evidence Blocks - Anal Carcinoma Version 4.2025
NCCN Guidelines with Evidence Blocks - Head and Neck Cancers Version 4.2025
NCCN Guidelines with Evidence Blocks - Histiocytic Neoplasms Version 1.2025
NCCN Guidelines with Evidence Blocks - Non-Small Cell Lung Cancer Version 5.2025
NCCN Guidelines with Evidence Blocks - Pediatric Hodgkin Lymphoma Version 2.2025
NCCN Guidelines with Evidence Blocks - Primary Cutaneous Lymphomas Version 3.2025
NCCN Guidelines with Evidence Blocks - Systemic Light Chain Amyloidosis Version 1.2026
Colorectal Cancer Screening Version 2.2025
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric Version 1.2025
Prostate Cancer Early Detection Version 2.2025
Hematopoietic Cell Transplantation Version 2.2025
Prevention and Treatment of Cancer-Related Infections Version 1.2025